Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

Prostate Cancer Metastatic

Brain Neoplasms

Carcinoma, Hepatocellular

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Pancreatic Neoplasms

Non-small Cell Lung Cancer Metastatic

Brain Neoplasms, Breast Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostate Adenocarcinoma

Carcinoma, Hepatocellular

Anxiety Disorders, Brain Neoplasms, Depression, Fatigue, Neoplasm Metastasis

Pancreatic Neoplasms

Pancreatic Neoplasms

Glioblastoma, Recurrence

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body

Pancreatic Neoplasms

Lung Neoplasms

Carcinoma, Hepatocellular

Neurocognitive Deficit

Colorectal Cancer Metastatic

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

Uveal Melanoma, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Patients With Advanced Metastatic Colorectal Cancer

Pancreatic Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

Non-Small Cell Lung Cancer Metastatic

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Brain Neoplasms

Breast Neoplasms

Glioblastoma

Pancreatic Neoplasms

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Clinical Trials

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

POSTILV

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection

Notable-HCC

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

HALT

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

K-SAB

SRSvsWBRT

IMMUNOs-SBRT

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

SAFO

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)

BRPCNCC-1

SBRT Plus vNKT for Pancreatic Cancer

TaRRGET

SCARCE

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

WHOBI-STER

COLLISION-XL

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

FIBROPANC-1

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence

SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases

5STAR-PC

Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

IMCORT-2

Noelia

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer

SOFT

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

CROP

HiSparCK

BoMB

CSREIG

MASTERPLAN

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

TASABR

An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

ISBRT01